This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Fusion protein of single-chain variable domain fragments and myasthenia gravis

July 10th, 2014

Single-chain variable domain fragment (scFv) 637 is an antigen-specific scFv of myasthenia gravis and it can bind to acetylcholine receptor in the residues 67-76 of α-subunit of acetylcholine receptor.

Dr. Fanping Meng and his team, College of Medicine, Yanbian University in China conjugated scFv and human serum albumin genes and detected the fusion protein in Pichia pastoris. Results showed that the fusion protein bound to acetylcholine receptors in neuromuscular junction of human intercostal muscle and the inhibition rate of fusion protein binding to acetycholine receptor was 2.0-77.4%, and the stability of fusion protein in static healthy sera was about 3 days. This approach suggests that scFV-human serum albumin is a potential candidate for specific immunosuppressive therapy of myasthenia gravis.

This paper was published in Neural Regeneration Research (Vol. 9, No. 8, 2014).

More information:
Li FF, Meng FP, Jin QX, Sun CY, Li YX, Li HH, Jin SZ. Fusion protein of single-chain variable domain fragments for treatment of myasthenia gravis. Neural Regen Res. 2014;9(8):851-856.

Provided by Neural Regeneration Research

Citation: Fusion protein of single-chain variable domain fragments and myasthenia gravis (2014, July 10) retrieved 24 April 2024 from https://sciencex.com/wire-news/166444161/fusion-protein-of-single-chain-variable-domain-fragments-and-mya.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.